Independent Director · Black Diamond Therapeutics, Inc. (BDTX)

Chair, Compensation Committee

Ali Behbahani director compensation at Black Diamond (FY2025): $115K

Fiscal year 2025 director compensation for Ali Behbahani at Black Diamond Therapeutics, Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 29, 2026 (DEF 14A). Open the filing on EDGAR.

Free

Get Ali Behbahani’s full pay file as a PDF — free

More than this page: up to 10 years of Ali’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Ali Behbahani and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

Black Diamond Therapeutics Director Compensation Table · all 4 fiscal years held
In US dollars, as Black Diamond Therapeutics reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$57,500$0$57,030$0$114,530
FY2024$57,500—$102,347$0$159,847
FY2023$47,788—$20,348$0$68,136
FY2021$52,500—$120,216$0$172,716

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Black Diamond Therapeutics, Inc. DEF 14A filed April 29, 2026, accession 0001104659-26-051474, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Black Diamond Therapeutics, Inc. filed document, accession 0001104659-26-051474. Every figure is read from that document and cited to the page and table it appears in. Filed April 29, 2026.

Get the Black Diamond Therapeutics Board Governance Report

$114,530 Ali Behbahani, FY2025 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 29, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2025

Black Diamond Therapeutics pays directors a $40,000 cash retainer and $57,030 in Options.

Committees

FY2025 · as the proxy prints them

Audit · Compensation (Chair)

The rest of the Black Diamond Therapeutics board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Garry E. MenzelIndependent Director$117,030
Kapil DhingraIndependent Director$105,030
Mark A. VellecaChair of the Board—
Prakash RamanIndependent Director$108,530
Samarth KulkarniLead Independent Director$126,030
Shannon CampbellIndependent Director$108,030

The full Black Diamond Therapeutics compensation record

free company brief

This page is one director within Black Diamond Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.

Order BDTX

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report